ALVO

Alvotech Ordinary Shares

$5.17

Current Price

All

AI analysis

Read what the AI thinks of Alvotech Ordinary Shares in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$0.63

P/E

—

Data as of Oct 1

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.05

Nov 11

Posts

No posts about ALVO yet.

About Alvotech Ordinary Shares

Alvotech is a biotechnology company based in Luxembourg and Iceland. It develops and makes biosimilars, which are lower-cost copies of expensive biologic drugs whose patents have expired. It earns money by selling these medicines and by partnering with larger drug companies that market them in different regions.